IR
Superintel
OverviewMarketsWatchlist
© 2026 IR SuperintelMethodologyContact

Tyndall Capital Partners L P

Q1 2017 Holdings

Filed 2017-05-15 | 3 holdings | $3.5K | 13F-HR | View on SEC ↗ · Holdings Table ↗

Sign in to see sub-manager breakdown

IssuerClassCUSIPValue ↓Shares% Portfolio
Onconova Therapeutics IncCOM NEW68232V306$1.6K520,83245.5%
MMA Cap Mgmt LLC(MMAC)COM55315D105$1.6K67,39945.1%
Onconova Therapeutics Inc*W EXP 07/07/20268232V116$327390,6249.4%